DENISE AMEZCUA: Open Payments
NPI 1861887853 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$586 in 28 payments from 9 companies in 2025. Trend: 2023 $269 · 2024 $719 · 2025 $586
Food & beverage: $586
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $172 |
| AstraZeneca Pharmaceuticals LP | 8 | $165 |
| Lilly USA, LLC | 3 | $76 |
| PFIZER INC. | 3 | $67 |
| Phathom Pharmaceuticals, Inc. | 2 | $29 |
| KYOWA KIRIN, INC. | 1 | $22 |
| Merck Sharp & Dohme LLC | 1 | $21 |
| Exact Sciences Corporation | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: FARXIGA, MOUNJARO, AIRSUPRA, NURTEC ODT, Rybelsus, Ozempic, VOQUEZNA, PAXLOVID.
Industry payments across CA — which companies pay providers there.
